Amgen | AMGN - Loan Capital

Stock Price
339.57
Daily Change
-0.61 -0.18%
Monthly
-2.70%
Yearly
17.68%
Q2 Forecast
337.18

Amgen reported $50B in Loan Capital for its fiscal quarter ending in December of 2025.





Loan Capital Change Date
AbbVie USD 62.97B 12M Sep/2025
Agios Pharmaceuticals USD 1.06M 0 Sep/2022
ALKERMES USD 285.82M 639K Sep/2024
Amgen USD 50B 2.43B Dec/2025
Biogen USD 6.29B 1.4M Sep/2025
BioMarin Pharmaceutical USD 597.18M 513K Dec/2025
Bristol-Myers Squibb USD 42.85B 1.62B Dec/2025
Coherus Biosciences USD 51.08M 496K Dec/2025
Eli Lilly USD 40.87B 5.6M Dec/2025
Genmab DKK 5.14B 5.01B Dec/2025
Gilead Sciences USD 22.13B 6M Dec/2025
GlaxoSmithKline GBP 14.71B 186M Dec/2025
Glaxosmithkline GBP 19.82B 203.13M Dec/2025
Incyte USD 29.41M 785K Mar/2026
Ionis Pharmaceuticals USD 1.9B 1.87B Dec/2025
J&J USD 37.53B 1.91B Mar/2026
Merck USD 39.97B 6B Sep/2025
Moderna USD 610M 584M Dec/2025
Neurocrine Biosciences USD 169.5M 500K Mar/2023
Novartis USD 29.59B 5.35B Dec/2025
Novartis USD 29.59B 5.35B Dec/2025
Pfizer USD 57.41B 93M Sep/2025
PTC Therapeutics USD 2.03B 193.22M Dec/2025
Puma Biotechnology USD 10.87M 222K Jun/2025
Regeneron Pharmaceuticals USD 1.99B 719.7M Mar/2026
Roche Holding CHF 27.43B 966M Dec/2025
Sanofi EUR 13.84B 1.88B Mar/2026
Sarepta Therapeutics USD 828.97M 206.17M Dec/2025
Takeda JPY 4.27T 81.29B Dec/2025
Teva Pharmaceutical Industries USD 14.99B 1.78B Dec/2025
Ultragenyx Pharmaceutical USD 763.74M 19.02M Sep/2025
Vertex Pharmaceuticals USD 111.4M 1.4M Mar/2025